Pharma Journalist - Page 65 of 923 -

Gilead Completes $7.8 Billion Arcellx Acquisition Deal

EU Approves Rhapsido for Chronic Hives Treatment

Lilly to Acquire Ajax in $2.3 Billion Deal

Capsida to Begin Phase 1/2 Trial of CAP-003 in Q3

Novo Nordisk Advances Amycretin for Weight Loss to Phase 3 Trials

BioNTech to Acquire CureVac in Strategic Public Exchange Deal

FDA Approves MAVYRET as First Treatment for Acute Hepatitis C

Enhancing Collaboration: Networking Opportunities at the Summit

FDA Approves Merck’s ENFLONSIA for RSV Prevention in Infants

YolTech Therapeutics Gets FDA Green Light for Gene-Editing Therapy YOLT-101 for HeFH

EU Approves Fixed-Duration Calquence Regimens for 1st-Line CLL

Aytu BioPharma Secures Exclusive US Rights for Novel Antidepressant EXXUA

Alnylam’s AMVUTTRA Wins EU Approval for ATTR Amyloidosis with Cardiomyopathy